EIGR
NASDAQEiger BioPharmaceuticals Inc.
Eiger BioPharmaceuticals Inc. (EIGR) is a Biotechnology: Biological Products (No Diagnostic Substances) company listed on NASDAQ. There were no new wire items for EIGR in the last 30 days. The most recent was published May 10, 2024.
Latest news
25 items- 13D/GSEC Form SC 13G/A filed by Eiger BioPharmaceuticals Inc. (Amendment)SC 13G/A - Eiger BioPharmaceuticals, Inc. (0001305253) (Subject)
- SECSEC Form 8-K filed by Eiger BioPharmaceuticals Inc.8-K - Eiger BioPharmaceuticals, Inc. (0001305253) (Filer)
- SECSEC Form 8-K filed by Eiger BioPharmaceuticals Inc.8-K - Eiger BioPharmaceuticals, Inc. (0001305253) (Filer)
- SECSEC Form 10-K/A filed by Eiger BioPharmaceuticals Inc. (Amendment)10-K/A - Eiger BioPharmaceuticals, Inc. (0001305253) (Filer)
- SECSEC Form 10-K filed by Eiger BioPharmaceuticals Inc.10-K - Eiger BioPharmaceuticals, Inc. (0001305253) (Filer)
- NEWS12 Health Care Stocks Moving In Thursday's After-Market SessionGainers Orgenesis (NASDAQ:ORGS) shares increased by 8.5% to $0.63 during Thursday's after-market session. The company's market cap stands at $21.4 million. AN2 Therapeutics (NASDAQ:ANTX) shares increased by 6.76% to $3.47. The company's market cap stands at $103.3 million. GRI Bio (NASDAQ:GRI) stock increased by 6.65% to $0.54. NuCana (NASDAQ:NCNA) shares rose 5.92% to $0.25. The market value of their outstanding shares is at $13.4 million. Stoke Therapeutics (NASDAQ:STOK) shares increased by 5.42% to $12.83. The company's market cap stands at $594.0 million. Candel Therapeutics (NASDAQ:CADL) stock moved upwards by 4.99% to $6.72. The market value of their outstanding shares is at $197
- NEWSWhy STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionShares of STAAR Surgical Company (NASDAQ:STAA) rose sharply during Thursday’s session after the company issued strong preliminary first-quarter net sales guidance. STAAR Surgical shares jumped 13.3% to $44.30 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers TC Biopharm (Holdings) Plc (NASDAQ:TCBP) shares climbed 130.1% to $2.9790. TCBP announced execution of non-binding letter of intent for acquisition of NK Platform Technologies. Allurion Technologies Inc. (NASDAQ:ALUR) gained 70% to $2.8801 after the company announced the commercial availability of its Virtual Care Suite in the United States. Also, Chardan Capital initiated coverage on the stock w
- NEWS12 Health Care Stocks Moving In Thursday's Intraday SessionGainers Candel Therapeutics (NASDAQ:CADL) shares moved upwards by 64.3% to $2.76 during Thursday's regular session. The market value of their outstanding shares is at $80.9 million. TC BioPharm (Holdings) (NASDAQ:TCBP) shares increased by 61.38% to $2.1. The market value of their outstanding shares is at $5.0 million. Eiger BioPharmaceuticals (NASDAQ:EIGR) shares moved upwards by 38.18% to $2.28. The company's market cap stands at $3.3 million. Macrogenics (NASDAQ:MGNX) stock rose 32.55% to $18.12. The company's market cap stands at $1.1 billion. Barinthus Biotherapeutics (NASDAQ:BRNS) shares increased by 29.55% to $3.77. The company's market cap stands at $146.7 million. Curis (NASDAQ
- NEWSWhy Flora Growth Shares Are Trading Lower By Around 20%; Here Are 20 Stocks Moving PremarketShares of Flora Growth Corp. (NASDAQ:FLGC) fell sharply in today’s pre-market trading after the company reported the launch of proposed underwritten public offering of common shares. Flora Growth shares tumbled 20.2% to $2.13 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers HWH International Inc. (NASDAQ:HWH) rose 175% to $4.32 in pre-market trading. Zhongchao Inc. (NASDAQ:ZCMD) gained 43% to $2.18 in pre-market trading after gaining 22% on Wednesday. Brooge Energy Limited (NASDAQ:BROG) gained 26.4% to $2.39 in pre-market trading after dipping over 20% on Wednesday. Sintx Technologies, Inc. (NASDAQ:SINT) shares rose 23.5% to $0.0284 in pre-ma
- NEWSEiger Biopharmaceuticals Says On April 2, Received Notice From Nasdaq That Co's Common Stock Will Be Delisted From Nasdaq; Common Stock Is Expected To Begin Trading On Over-Counter Market On April 11- SEC Filing
- SECSEC Form 8-K filed by Eiger BioPharmaceuticals Inc.8-K - Eiger BioPharmaceuticals, Inc. (0001305253) (Filer)
- NEWS12 Health Care Stocks Moving In Wednesday's After-Market SessionGainers Aesthetic Medical Intl (NASDAQ:AIH) shares rose 14.0% to $0.52 during Wednesday's after-market session. The company's market cap stands at $24.9 million. Kineta (NASDAQ:KA) shares rose 8.46% to $0.58. The company's market cap stands at $6.3 million. Simulations Plus (NASDAQ:SLP) shares increased by 6.74% to $40.99. The market value of their outstanding shares is at $818.4 million. As per the news, the Q2 earnings report came out today. Bolt Biotherapeutics (NASDAQ:BOLT) shares moved upwards by 6.66% to $1.44. The company's market cap stands at $54.9 million. Eiger BioPharmaceuticals (NASDAQ:EIGR) shares increased by 6.66% to $1.76. The market value of their outstanding shares is
- SECSEC Form NT 10-K filed by Eiger BioPharmaceuticals Inc.NT 10-K - Eiger BioPharmaceuticals, Inc. (0001305253) (Filer)
- SECSEC Form S-8 POS filed by Eiger BioPharmaceuticals Inc.S-8 POS - Eiger BioPharmaceuticals, Inc. (0001305253) (Filer)
- SECSEC Form S-8 POS filed by Eiger BioPharmaceuticals Inc.S-8 POS - Eiger BioPharmaceuticals, Inc. (0001305253) (Filer)
- SECSEC Form S-8 POS filed by Eiger BioPharmaceuticals Inc.S-8 POS - Eiger BioPharmaceuticals, Inc. (0001305253) (Filer)
- SECSEC Form S-8 POS filed by Eiger BioPharmaceuticals Inc.S-8 POS - Eiger BioPharmaceuticals, Inc. (0001305253) (Filer)
- SECSEC Form S-8 POS filed by Eiger BioPharmaceuticals Inc.S-8 POS - Eiger BioPharmaceuticals, Inc. (0001305253) (Filer)
- SECSEC Form S-8 POS filed by Eiger BioPharmaceuticals Inc.S-8 POS - Eiger BioPharmaceuticals, Inc. (0001305253) (Filer)
- SECSEC Form S-8 POS filed by Eiger BioPharmaceuticals Inc.S-8 POS - Eiger BioPharmaceuticals, Inc. (0001305253) (Filer)
- SECSEC Form S-8 POS filed by Eiger BioPharmaceuticals Inc.S-8 POS - Eiger BioPharmaceuticals, Inc. (0001305253) (Filer)
- SECSEC Form S-8 POS filed by Eiger BioPharmaceuticals Inc.S-8 POS - Eiger BioPharmaceuticals, Inc. (0001305253) (Filer)
- SECSEC Form S-8 POS filed by Eiger BioPharmaceuticals Inc.S-8 POS - Eiger BioPharmaceuticals, Inc. (0001305253) (Filer)
- SECSEC Form S-8 POS filed by Eiger BioPharmaceuticals Inc.S-8 POS - Eiger BioPharmaceuticals, Inc. (0001305253) (Filer)
- SECEiger BioPharmaceuticals Inc. filed SEC Form 8-K: Bankruptcy or Receivership8-K - Eiger BioPharmaceuticals, Inc. (0001305253) (Filer)
EIGR FAQ
8 questionsWhat does Eiger BioPharmaceuticals Inc. do?
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to treat hepatitis delta virus infection. The company's product candidate also include Lambda, which targets type III interferon receptors that has completed Phase II clinical trials; Lonafarnib for the treatment of progeria and progeroid laminopathies...What is the latest news on EIGR?
Quantisnow has not tracked any new filings, ratings or press releases for EIGR in the last 30 days. The most recent wire item was published on May 10, 2024.Where does EIGR stock trade?
Eiger BioPharmaceuticals Inc. (EIGR) is listed on NASDAQ.What sector and industry is EIGR in?
Eiger BioPharmaceuticals Inc. operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.When did Eiger BioPharmaceuticals Inc. go public?
Eiger BioPharmaceuticals Inc. (EIGR) completed its IPO in 2014.What are analysts saying about EIGR?
Eiger BioPharmaceuticals Inc. has had 1 recent analyst action on file. The most recent action was from Citigroup: Buy with a $27.00 price target on 2021-08-09. Recent price targets cluster around $27.00.What companies are similar to EIGR?
Notable peers in the same industry include AMGN (Amgen Inc.), GILD (Gilead Sciences Inc.), MRNA (Moderna Inc.), ARGX (argenx SE), RVMD (Revolution Medicines Inc.). Compare EIGR side-by-side with any of them on Quantisnow.How can I track EIGR on Quantisnow?
Quantisnow aggregates Eiger BioPharmaceuticals Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow EIGR to receive live email and push alerts on every new disclosure.